We are Sorry, This Page doesn't Exist
Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update
LA JOLLA, Calif., April 14, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a cl.....»»
Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update
LA JOLLA,.....»»
Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
LA JOLLA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and .....»»
Artelo Biosciences reports Q2 EPS (11c), two estimates (11c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kaleido Biosciences reports results from non-IND study of KB109
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Artelo Biosciences announces pre-clinical data on CBD Cocrystal
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update
Dosed First Patient in Phase 1/2a Clinical Study of PBCAR20A in R.....»»
Willow Biosciences Reports First Quarter 2020 Results And Operational Update
CALGARY, May 14, 2020 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") ((TSX: WLLW, OTCQB:CANSF) has released its financial and operating results for the three months ended March 31, 2020. Statement f.....»»
Willow Biosciences Reports First Quarter 2020 Results And Operational Update
CALGARY, May 14, 2020 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") ((TSX: WLLW, OTCQB:CANSF) has released its financial and operating results for the three months ended March 31, 2020. Statement from the CEO "We took a major step forwa.....»»
SpringWorks Therapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights
- Announced Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Nirogacestat, Extending Patent Protection into 2039 -Â - Signed Clinical Collaboration with Allogene to Evaluate Nirogacestat in Combination with Allog.....»»
IDEAYA Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., May 12, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics.....»»
Evelo Biosciences Reports First Quarter Financial Results and Business Highlights
–Submitted investigational new drug (IND) application for a Phase 2 trial of EDP1815 for COVID-19; data readout expected during.....»»
Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
-- Total revenues increased 16 percent over prior year first quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020.....»»
Selecta Biosciences Reports First Quarter 2020 Financial Results
- Topline data announcement from the ongoing head-to-head COMPARE trial of SEL-212 remains on schedule for Q3 2020 - - Phase 3 clinical program of SEL-212 to com.....»»
Artelo Biosciences reports Q2 EPS (40c), one est. (55c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kuros Biosciences Reports Results for the Full Year 2019
Financial highlights CHF 21.9 million .....»»
Willow Biosciences Reports Fourth Quarter and 2019 Year End Results and Operational Update
CALGARY, March 24, 2020 /PRNewswire/ - Will.....»»
Willow Biosciences Reports Fourth Quarter and 2019 Year End Results and Operational Update
CALGARY, March 24, 2020 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") ((TSX:Â.....»»
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ --Â IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using .....»»
Liminal Biosciences Reports Fourth Quarter and 2019 Year End Results
Key 2019 Events: $114.4 million aggregate gross proceeds were raised through a combination of a private placement offering of .....»»